Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

June 17th 2020, Crypto Chartbook: Failure equals big money

Failure equals big money If that be the case we’d be all rich trading the markets. No, what we are referring here to is pattern failure. Chart patterns have probabilities of how often they work. Most bet in favor of the favorable outcome of such patterns. ...
Korbinian Koller | June 17, 2020 |

GlucoTrack: Company Addresses the Diabetes Testing and Monitoring Conundrum

GlucoTrack ( NDAQ:GCTK ) is an American medical device company focused on design, development and commercialization. The company is developing proprietary painless and non-invasive blood glucose monitoring devices for both Type 2 diabetes and prediabetes, a market almost ...
Simon Druker | January 16, 2023 |

Mandalay Resources: A Canadian resource company with an international focus

Mandalay Resources is a Toronto-based natural resource company with an international focus. The precious metals explorer already has producing assets in Australia and Sweden. Its focus remains on furthering growth at both operations, reducing associated costs where it can...
Simon Druker | October 24, 2022 |

Checking in on Gold & Silver Sentiment

The precious metals sector remains in a correction. The miners have shown some positive signs but are not ready to move yet because the metals likely have more correction ahead. Technical support levels can provide us with low risk buy opportunities but combine that with s...
Jordan Roy-Byrne, CMT | November 27, 2019 |

The Next Catalyst for Gold

The precious metals sector remains in a correction, and as long as the 200-day moving averages hold, a bullish consolidation that began last September. Sure, Gold made a new high and is still holding around the previous high, but the rest of the sector has not confirmed th...
Jordan Roy-Byrne, CMT | January 23, 2020 |

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. Prior to the U.S. markets open this morning on the first day of trading in 2020, clinical...
Streetwise Reports | January 3, 2020 |

Why This Gold Stock is Up 171% Year-to-date

Although Ontario is Canada’s largest producer of gold, out west in British Columbia, the province is fourth only behind Quebec and Nunavut. British Columbia also hosts the infamous Golden Triangle, situated in the northern region of the province close to t...
Jocelyn Aspa | June 17, 2021 |

Permex Petroleum: A uniquely positioned junior oil & gas company

The world of oil and gas has been fascinating to watch recently as issues with the global supply chain and ongoing war with Russia and Ukraine have seen prices hit decades-long highs, leading the U.S. government to tap into its strategic reserves and URGE domestic produce...
Daniella Atkinson | October 24, 2022 |

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

April 15th 2020, Crypto Chartbook: Evolve or die

Evolve or die That might be too strong a title, but it’s not! The law of evolution is principle based, saying that adoption is required especially in times of rapid change. It is without a question such a time. For example, a successful carburetor spe...
Korbinian Koller | April 15, 2020 |
1 2 3 4 5 6 7 8 9 10 ...